Close Menu

Personalized medicine, says this article in The Scientist, could breathe new life into failed drug candidates. "If Merck could have known in advance who would have cardiovascular problems from Vioxx, they may not have had to withdraw it from the market," Personalized Medicine Coalition's Edward Abrahams says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.